search
Back to results

Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream

Primary Purpose

Dentin Sensitivity

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Control toothpaste containing Novamin® technology
Control toothpaste containing 1500 ppm fluoride as MFP
Test toothpaste with nano-HAP (high concentration)
Test toothpaste with nano-HAP (low concentration)
Test toothpaste with nano-HAP and (Potassium Nitrate) KNO3
Control toothpaste without nano-HAP
Test toothpaste with nano-HAP (medium concentration)
Test cream with nano-HAP (higher concentration)
Control cream without nano-HAP
Sponsored by
The University of Texas Health Science Center at San Antonio
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dentin Sensitivity focused on measuring dentin hypersensitivity, nanohydroxyapatite, calcium sodium phosphosilicate, toothpaste, tooth cream

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Must be between the ages of 18 and 80, inclusive
  • Must be in good general health based on medical history and oral soft and hard tissue examinations
  • Must be willing and able to provide informed consent
  • Must be able to read and comprehend study materials
  • Must have access to a phone for regular study contact
  • Must be willing to use the assigned products according to instructions, and be availability for appointments.
  • Must have been diagnosed of having dentin hypersensitivity by a dentist, with at least one sensitive tooth with demonstrated cervical erosion/abrasion or gingival recession
  • As a final entrance criteria, the sensitive tooth must respond to:

    • air sensitivity, with Schiff score >1, assessed by use of a one-second blast of air.
    • thermal sensitivity, assessed with frozen cotton pellet, with a pain rating of at least moderate pain on the Dental Pain Scale (DPS) and a score between 30 and 80 mm on a 100 mm scale on the Visual Analog Scale (VAS).

Exclusion Criteria:

  • Subjects who answer YES to any of the following questions will not be enrolled into the study:

    • Any history of significant adverse effects following use of oral hygiene products such as toothpastes and mouthwashes?
    • Does the subject have any physical limitations or restrictions that might preclude use of normal oral hygiene procedures (i.e., toothbrushing, mouthrinsing, etc.)?
    • The sensitive tooth is associated with concomitant oral pain due to any other condition such as: soft-tissue lesions or toothache from other dental conditions like dental caries, etc?
    • Has the subject ever reported allergy to drugs or chemicals used in the trial?
    • The sensitive tooth is associated with a periodontal abscess as diagnosed from an X-ray or clinical examination of the tooth?
    • Will the subject receive dental treatment which may affect their participation (i.e. oral prophylaxis)?
    • The sensitive tooth is associated with mobility > 1?
    • Did the subject participate in a dental clinical trial involving oral care products within the past 30 days?
    • Is the subject pregnant, nursing or planning to become pregnant during the course of the study (self-reported)?
    • Does the subject have other severe, acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial result and, in the judgment of the investigator, would make the subject inappropriate for entry into this trial?
    • Does the subject have significant oral soft tissue pathology, based on the dentist's visual examination and at the discretion of the investigator?
    • The sensitive tooth is associated with gum pain from gingivitis, occlusal trauma, thermal or chemical burns?
    • Patients having pain from periodontal related causes but not dentin hypersensitivity?
    • Previous professional desensitizing treatment?
    • Subject use of over-the-counter desensitizing products within the previous 3 months?
    • Subjects using medication which could interfere with the perception of pain?
    • Eating disorders or conditions associated with vomiting?
    • Systemic conditions that are etiologic or predisposing to dentinal hypersensitivity?
    • Excessive dietary or environmental exposure to acids?
    • The sensitive tooth was restored in the preceding 3 months?
    • The sensitive tooth is an abutment tooth for fixed or removable prostheses?
    • The sensitive tooth has extensive restorations or restoration extending into the test area?
    • Patients below 18 years or above 80 years of age?

Sites / Locations

  • School of Dentistry, University of Texas Health Science Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm Type

Active Comparator

Placebo Comparator

Experimental

Experimental

Experimental

Placebo Comparator

Experimental

Experimental

Placebo Comparator

Arm Label

Control toothpaste containing Novamin® technology

Control toothpaste containing 1500 ppm fluoride as MFP

Test toothpaste with nano-HAP (high concentration)

Test toothpaste with nano-HAP (low concentration)

Test toothpaste with nano-HAP and potassium nitrate (KNO3)

Control toothpaste without nano-HAP

Test toothpaste with nano-HAP (medium concentration)

Test cream with nano-HAP (higher concentration)

Control cream without nano-HAP

Arm Description

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).

Participants will be instructed to brush for 2 minutes morning and evening with a full ribbon of standard fluoride toothpaste. After the evening brushing, participants will then insert custom-made trays loaded with a full ribbon of cream. Participants will be instructed to remove the trays after 5 minutes and expectorate the cream. Participants will be instructed not to eat or drink until the next morning following cream use.

Participants will be instructed to brush for 2 minutes morning and evening with a full ribbon of standard fluoride toothpaste. After the evening brushing, participants will then insert custom-made trays loaded with a full ribbon of cream. Participants will be instructed to remove the trays after 5 minutes and expectorate the cream. Participants will be instructed not to eat or drink until the next morning following cream use.

Outcomes

Primary Outcome Measures

Percentage Change From Baseline in VAS (Visual Analog Scale) With Air Stimulation
Patient's response to an air stimulus is recorded on a Visual Analog Scale of 0-100 with 0 representing no pain and 100 representing the worst possible pain.
Percentage Change From Baseline in VAS (Visual Analog Scale) With Cold Stimulation
Patient's response to cold stimulus is recorded on a Visual Analog Scale of 0-100 with 0 signifying no pain and 100 signifying the worst possible pain
Percentage Change From Baseline in DPS (Dental Pain Scale) With Air Stimulation
Patient's response to an air stimulus is recorded on a Dental Pain Scale (none[1]-mild[2]-moderate[3]-severe[4]).
Percentage Change From Baseline in DPS (Dental Pain Scale) With Cold Stimulation
Patient's response to an cold stimulus is recorded on a Dental Pain Scale (none[1]-mild[2]-moderate[3]-severe[4]).

Secondary Outcome Measures

Full Information

First Posted
September 13, 2016
Last Updated
October 18, 2018
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Sangi Co., Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT02918617
Brief Title
Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
Official Title
Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
May 2015 (Actual)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Sangi Co., Ltd.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will investigate the effectiveness of nanohydroxyapatite (nano-HAP)-containing toothpastes and cream to relieve dentin hypersensitivity, comparing it with those of a commercial desensitizing dentifrice containing calcium sodium phosphosilicate (Novamin® technology) and a standard fluoride dentifrice containing 1,500 ppm fluoride as sodium monofluorophosphate (MFP).
Detailed Description
This is a double-blind, randomized, controlled, parallel group, outpatient clinical trial, involving a total of 270 patients diagnosed with dentin hypersensitivity, who will be randomly assigned to nine treatment groups of 30 patients each. Males or females of age 18 to 80 years will be enrolled. The nine groups will be randomly assigned to use one of the nine test products: (1) toothpaste containing nano-HAP (high concentration); (2) toothpaste containing nano-HAP (low concentration); (3) toothpaste containing nano-HAP and potassium nitrate (KNO3); (4) toothpaste containing NovaMin; (5) standard fluoride toothpaste with 1500 ppm MFP; (6) toothpaste containing nano-HAP (medium concentration); (7) placebo toothpaste; (8) cream containing nano-HAP; (9) placebo cream. Subjects will be instructed to use the study toothpaste as their sole oral hygiene product for the 8 weeks treatment duration while the cream will be applied with a retainer tray for 5 minutes before bed at night. For those using toothpastes, subjects will be instructed to brush their teeth twice daily for 2 minutes, morning and last thing before bed, applying on each occasion a one-inch strip of their assigned toothpaste on a wetted commercially available soft-bristled toothbrush. Dentin hypersensitivity examination, which will include air blast sensitivity and cold thermal sensitivity combined with visual analog scale and Dental Pain Scale, will be conducted at baseline, 2, 4, 6, and 8 weeks. Subjects will be screened for adverse effects on every visit, and all observed adverse events will be recorded when they occur.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dentin Sensitivity
Keywords
dentin hypersensitivity, nanohydroxyapatite, calcium sodium phosphosilicate, toothpaste, tooth cream

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
203 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control toothpaste containing Novamin® technology
Arm Type
Active Comparator
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Control toothpaste containing 1500 ppm fluoride as MFP
Arm Type
Placebo Comparator
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Test toothpaste with nano-HAP (high concentration)
Arm Type
Experimental
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Test toothpaste with nano-HAP (low concentration)
Arm Type
Experimental
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Test toothpaste with nano-HAP and potassium nitrate (KNO3)
Arm Type
Experimental
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Control toothpaste without nano-HAP
Arm Type
Placebo Comparator
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Test toothpaste with nano-HAP (medium concentration)
Arm Type
Experimental
Arm Description
Participants will be instructed to apply a full ribbon of toothpaste to a damp toothbrush. Participants will then brush for 2 minutes followed by rinsing with 15 mL of water. Participants will be instructed not to eat or drink for 30 minutes following brushing. Brushing will be performed twice a day (morning and evening).
Arm Title
Test cream with nano-HAP (higher concentration)
Arm Type
Experimental
Arm Description
Participants will be instructed to brush for 2 minutes morning and evening with a full ribbon of standard fluoride toothpaste. After the evening brushing, participants will then insert custom-made trays loaded with a full ribbon of cream. Participants will be instructed to remove the trays after 5 minutes and expectorate the cream. Participants will be instructed not to eat or drink until the next morning following cream use.
Arm Title
Control cream without nano-HAP
Arm Type
Placebo Comparator
Arm Description
Participants will be instructed to brush for 2 minutes morning and evening with a full ribbon of standard fluoride toothpaste. After the evening brushing, participants will then insert custom-made trays loaded with a full ribbon of cream. Participants will be instructed to remove the trays after 5 minutes and expectorate the cream. Participants will be instructed not to eat or drink until the next morning following cream use.
Intervention Type
Drug
Intervention Name(s)
Control toothpaste containing Novamin® technology
Intervention Type
Drug
Intervention Name(s)
Control toothpaste containing 1500 ppm fluoride as MFP
Intervention Type
Drug
Intervention Name(s)
Test toothpaste with nano-HAP (high concentration)
Intervention Type
Drug
Intervention Name(s)
Test toothpaste with nano-HAP (low concentration)
Intervention Type
Drug
Intervention Name(s)
Test toothpaste with nano-HAP and (Potassium Nitrate) KNO3
Intervention Type
Drug
Intervention Name(s)
Control toothpaste without nano-HAP
Intervention Type
Drug
Intervention Name(s)
Test toothpaste with nano-HAP (medium concentration)
Intervention Type
Drug
Intervention Name(s)
Test cream with nano-HAP (higher concentration)
Intervention Type
Drug
Intervention Name(s)
Control cream without nano-HAP
Primary Outcome Measure Information:
Title
Percentage Change From Baseline in VAS (Visual Analog Scale) With Air Stimulation
Description
Patient's response to an air stimulus is recorded on a Visual Analog Scale of 0-100 with 0 representing no pain and 100 representing the worst possible pain.
Time Frame
Baseline to 8 weeks
Title
Percentage Change From Baseline in VAS (Visual Analog Scale) With Cold Stimulation
Description
Patient's response to cold stimulus is recorded on a Visual Analog Scale of 0-100 with 0 signifying no pain and 100 signifying the worst possible pain
Time Frame
Baseline to 8 weeks
Title
Percentage Change From Baseline in DPS (Dental Pain Scale) With Air Stimulation
Description
Patient's response to an air stimulus is recorded on a Dental Pain Scale (none[1]-mild[2]-moderate[3]-severe[4]).
Time Frame
Baseline to 8 weeks
Title
Percentage Change From Baseline in DPS (Dental Pain Scale) With Cold Stimulation
Description
Patient's response to an cold stimulus is recorded on a Dental Pain Scale (none[1]-mild[2]-moderate[3]-severe[4]).
Time Frame
Baseline to 8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Must be between the ages of 18 and 80, inclusive Must be in good general health based on medical history and oral soft and hard tissue examinations Must be willing and able to provide informed consent Must be able to read and comprehend study materials Must have access to a phone for regular study contact Must be willing to use the assigned products according to instructions, and be availability for appointments. Must have been diagnosed of having dentin hypersensitivity by a dentist, with at least one sensitive tooth with demonstrated cervical erosion/abrasion or gingival recession As a final entrance criteria, the sensitive tooth must respond to: air sensitivity, with Schiff score >1, assessed by use of a one-second blast of air. thermal sensitivity, assessed with frozen cotton pellet, with a pain rating of at least moderate pain on the Dental Pain Scale (DPS) and a score between 30 and 80 mm on a 100 mm scale on the Visual Analog Scale (VAS). Exclusion Criteria: Subjects who answer YES to any of the following questions will not be enrolled into the study: Any history of significant adverse effects following use of oral hygiene products such as toothpastes and mouthwashes? Does the subject have any physical limitations or restrictions that might preclude use of normal oral hygiene procedures (i.e., toothbrushing, mouthrinsing, etc.)? The sensitive tooth is associated with concomitant oral pain due to any other condition such as: soft-tissue lesions or toothache from other dental conditions like dental caries, etc? Has the subject ever reported allergy to drugs or chemicals used in the trial? The sensitive tooth is associated with a periodontal abscess as diagnosed from an X-ray or clinical examination of the tooth? Will the subject receive dental treatment which may affect their participation (i.e. oral prophylaxis)? The sensitive tooth is associated with mobility > 1? Did the subject participate in a dental clinical trial involving oral care products within the past 30 days? Is the subject pregnant, nursing or planning to become pregnant during the course of the study (self-reported)? Does the subject have other severe, acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial result and, in the judgment of the investigator, would make the subject inappropriate for entry into this trial? Does the subject have significant oral soft tissue pathology, based on the dentist's visual examination and at the discretion of the investigator? The sensitive tooth is associated with gum pain from gingivitis, occlusal trauma, thermal or chemical burns? Patients having pain from periodontal related causes but not dentin hypersensitivity? Previous professional desensitizing treatment? Subject use of over-the-counter desensitizing products within the previous 3 months? Subjects using medication which could interfere with the perception of pain? Eating disorders or conditions associated with vomiting? Systemic conditions that are etiologic or predisposing to dentinal hypersensitivity? Excessive dietary or environmental exposure to acids? The sensitive tooth was restored in the preceding 3 months? The sensitive tooth is an abutment tooth for fixed or removable prostheses? The sensitive tooth has extensive restorations or restoration extending into the test area? Patients below 18 years or above 80 years of age?
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bennett T Amaechi, BDS, MS, PhD
Organizational Affiliation
University of Texas Health Science Center San Antonio
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Dentistry, University of Texas Health Science Center
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
2197126
Citation
Clark GE, Troullos ES. Designing hypersensitivity clinical studies. Dent Clin North Am. 1990 Jul;34(3):531-44.
Results Reference
background
PubMed Identifier
8951626
Citation
Gillam DG, Bulman JS, Jackson RJ, Newman HN. Efficacy of a potassium nitrate mouthwash in alleviating cervical dentine sensitivity (CDS). J Clin Periodontol. 1996 Nov;23(11):993-7. doi: 10.1111/j.1600-051x.1996.tb00526.x.
Results Reference
background
Citation
Kakar A. A novel computer program for visual analogue scale (VAS). Journal of Dental Research 88 (Special Issue A): 1952, 2009.
Results Reference
background
PubMed Identifier
4139420
Citation
Huskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889):1127-31. doi: 10.1016/s0140-6736(74)90884-8. No abstract available.
Results Reference
background
PubMed Identifier
8534379
Citation
Orro M, Truong T, De Vizio W, Miller S, Chu TC, Boylan D. Thermodontic stimulator--a new technology for assessment of thermal dentinal hypersensitivity. J Clin Dent. 1994;5 Spec No:83-6.
Results Reference
background
PubMed Identifier
8534380
Citation
Schiff T, Dotson M, Cohen S, De Vizio W, McCool J, Volpe A. Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study. J Clin Dent. 1994;5 Spec No:87-92.
Results Reference
background
PubMed Identifier
19831164
Citation
Ayad F, Ayad N, Delgado E, Zhang YP, DeVizio W, Cummins D, Mateo LR. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada. J Clin Dent. 2009;20(4):115-22.
Results Reference
background

Learn more about this trial

Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream

We'll reach out to this number within 24 hrs